Join
Live feed
·
INSIDERFilingvia Quantisnow
Agios Pharmaceuticals Inc. logo

Chief Commercial Officer Milanova Tsveta converted options into 9,666 shares and sold $83,057 worth of shares (2,868 units at $28.96), increasing direct ownership by 20% to 41,591 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGIO (Agios Pharmaceuticals Inc.) and more on Quantisnow.